I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Long-term (up to 4.5 years) treatment with fingolimod in mu..:
Cohen, Jeffrey A
;
Khatri, Bhupendra
;
Barkhof, Frederik
...
info:eu-repo/semantics/altIdentifier/doi/10.1136/jnnp-2015-310597. , 2016
Link:
https://amu.hal.science/hal-01419490
RT Journal T1
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study
UL https://suche.suub.uni-bremen.de/peid=base-ftunivaixmarseil:oai:HAL:hal-01419490v1&Exemplar=1&LAN=DE A1 Cohen, Jeffrey A A1 Khatri, Bhupendra A1 Barkhof, Frederik A1 Comi, Giancarlo A1 Hartung, Hans-Peter A1 Montalban, Xavier A1 Pelletier, Jean A1 Stites, Tracy A1 Ritter, Shannon A1 Rosenstiel, Philipp, Von A1 Tomic, Davorka A1 Kappos, Ludwig A1 Rrms) Study Group, Transforms (trial Assessing, Injectable Interferon Vs. Fty720 Oral In PB HAL CCSD; BMJ Publishing Group YR 2016 K1 Adult K1 Disability Evaluation K1 Double-Blind Method K1 Female K1 Fingolimod Hydrochloride K1 Humans K1 Immunosuppressive Agents K1 Interferon beta-1a K1 Magnetic Resonance Imaging K1 Male K1 Multiple Sclerosis K1 Relapsing-Remitting K1 Neuroimaging K1 Recurrence K1 Treatment Outcome K1 Young Adult K1 [SDV.IB]Life Sciences [q-bio]/Bioengineering JF info:eu-repo/semantics/altIdentifier/doi/10.1136/jnnp-2015-310597 LK http://dx.doi.org/https://amu.hal.science/hal-01419490 DO https://amu.hal.science/hal-01419490 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)